东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02348 东瑞制药

休市中 01-23 15:53:55

1.170

+0.000

0.00%

最高1.170	最低1.160	成交量54.80万
今开1.170	昨收1.170	日振幅0.85%
总市值17.59亿	流通市值17.59亿	总股本15.03亿
成交额63.68万	换手率0.04%	流通股本15.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":1.17,"timestamp":1769154835693,"preClose":1.17,"halted":0,"volume":548000,"delay":0,"changeRate":0,"floatShares":1503000000,"shares":1503000000,"eps":0.37541,"marketStatus":"休市中","change":0,"latestTime":"01-23 15:53:55","open":1.17,"high":1.17,"low":1.16,"amount":636800,"amplitude":0.008547,"askPrice":1.17,"askSize":68000,"bidPrice":1.16,"bidSize":224000,"shortable":0,"etf":0,"ttmEps":0.128418,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769391000000},"marketStatusCode":7,"adr":0,"listingDate":1057852800000,"exchange":"SEHK","adjPreClose":1.17,"dividendRate":0.081197,"openAndCloseTimeList":[[1769131800000,1769140800000],[1769144400000,1769155200000]],"volumeRatio":1.229802513740979,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"2605282135","title":"东瑞制药01月23日主力净流出26.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605282135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605282135?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156111,"startTime":"0","endTime":"0","summary":"01月23日，东瑞制药股价收平报1.17元，成交金额63.7万元，换手率0.04%，振幅0.85%，量比1.23。东瑞制药今日主力资金净流出26.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.50%，主力资金累计净流出26.0万元；近20日主力资金累计净流出26.0万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161557a44d82af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161557a44d82af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"1155715444","title":"东瑞制药（控股）（02348）公布2025年12月月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1155715444","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155715444?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:12","pubTimestamp":1767690773,"startTime":"0","endTime":"0","summary":"东瑞制药（控股）有限公司于2026年1月6日发布截至2025年12月31日的月报表。报告显示，公司法定股本维持在20,000,000,000股，对应总额HKD 1,000,000,000，未发生变动。公司已发行普通股于期末为1,503,357,000股，与上月保持一致，无购回或注销活动，也无新增发行及库藏股变动。截至2025年12月31日，公司股本结构保持稳定，合计已发行股份总数为1,503,357,000股。公司确认遵守香港联合交易所有限公司《上市规则》及相关法律规定，本次月报表由公司秘书彭洁玲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02348"],"gpt_icon":0},{"id":"2589382961","title":"36个品种拟进院，独家品种占比超35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589382961","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589382961?lang=zh_cn&edition=full","pubTime":"2025-12-06 19:21","pubTimestamp":1765020078,"startTime":"0","endTime":"0","summary":"36款拟引进的新药中，独家品种占比超35%，涉及复方鳖甲软肝片、地达西尼胶囊、递法明片等潜力品种；另有12个国采品种在列，石药集团、华海药业、倍特药业等集采中选企业优势十足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","06887","01093","BK1191"],"gpt_icon":0},{"id":"2581409556","title":"主席李其玲增持东瑞制药(02348)5.2万股 每股作价1.22港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581409556","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581409556?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:18","pubTimestamp":1762435135,"startTime":"0","endTime":"0","summary":"11月3日，主席李其玲增持东瑞制药(02348)5.2万股，每股作价1.22港元，总金额约为6.34万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20251106/20251106211431_39464.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251106/20251106211431_39464.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2579431947","title":"东瑞制药10月30日主力净流入8.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579431947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579431947?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812114,"startTime":"0","endTime":"0","summary":"10月30日，东瑞制药股价收平报1.20元，成交金额112.3万元，换手率0.06%，振幅0.83%，量比2.18。东瑞制药今日主力资金净流入8.4万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.45%，主力资金累计净流入8.4万元；近20日主力资金累计净流入8.4万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016154694e5211a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016154694e5211a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"1156041766","title":"异动解读 | 东瑞制药中期业绩大幅下滑，股价盘中大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156041766","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156041766?lang=zh_cn&edition=full","pubTime":"2025-08-25 09:32","pubTimestamp":1756085579,"startTime":"0","endTime":"0","summary":"周一盘中，东瑞制药股价大跌6.98%，投资者对公司最新公布的中期业绩表现失望。根据公司公告，东瑞制药2025年上半年业绩出现明显下滑。公司报告期内实现收入约6.3亿元人民币，同比下降9.2%。更值得注意的是，公司净利润仅为1.05亿元人民币，同比大幅下滑78.8%。每股盈利降至0.06961元人民币，相比去年同期出现显著下降。尽管业绩表现不佳，东瑞制药仍维持派发中期股息0.015港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02348"],"gpt_icon":0},{"id":"1157213067","title":"异动解读 | 业绩大幅下滑，东瑞制药盘中大跌近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157213067","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157213067?lang=zh_cn&edition=full","pubTime":"2025-08-25 09:32","pubTimestamp":1756085566,"startTime":"0","endTime":"0","summary":"东瑞制药（02348.HK）今日盘中大跌6.98%，引发市场关注。这一股价走势与公司最新发布的中期业绩报告密切相关。\n\n根据公司公告，东瑞制药2025年上半年业绩出现明显下滑。期内，公司录得收入6.3亿元人民币，同比下降9.2%；净利润为1.05亿元人民币，同比大幅下滑78.8%。每股盈利降至0.06961元人民币。尽管业绩下滑，公司仍维持中期派息1.5港仙。\n\n分析人士认为，东瑞制药净利润的大幅下滑是引发股价下跌的主要原因。这一业绩表现可能引发投资者对公司未来盈利能力的担忧，从而导致股价承压。市场将密切关注公司后续的经营策略调整和业绩改善措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02348"],"gpt_icon":0},{"id":"2562936582","title":"东瑞制药公布中期业绩 归母应占溢利约1.05亿元同比减少78.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562936582","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562936582?lang=zh_cn&edition=full","pubTime":"2025-08-25 08:36","pubTimestamp":1756082160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　东瑞制药（02348）公布2025年中期业绩，收入约6.3亿元，同比增长9.2%；毛利约3.14亿元，同比减少7.1%；母公司拥有人应占溢利约1.05亿元，同比减少78.79%；每股盈利0.06961元，每股中期股息0.015港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-08-25/doc-infnczmp9345472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2561032134","title":"东瑞制药(02348)公布中期业绩 母公司拥有人应占溢利约1.05亿元 同比减少78.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561032134","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561032134?lang=zh_cn&edition=full","pubTime":"2025-08-22 22:53","pubTimestamp":1755874421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药 公布2025年中期业绩，收入约6.3亿元，同比增长9.2%;毛利约3.14亿元，同比减少7.1%;母公司拥有人应占溢利约1.05亿元，同比减少78.79%;每股盈利0.06961元，每股中期股息0.015港元。公告称，本期间溢利下降主要是苏州东瑞善丰路厂区和兰州东瑞未形成规模化的商业化生产、“安”系列等集采品种受国家政策影响部分省份价格下降以及研发费用增加所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"东瑞制药(02348)公布中期业绩 母公司拥有人应占溢利约1.05亿元 同比减少78.79%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2558809652","title":"东瑞制药8月22日举行董事会会议考虑及批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2558809652","media":"格隆汇资讯","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558809652?lang=zh_cn&edition=full","pubTime":"2025-08-11 17:42","pubTimestamp":1754905350,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨东瑞制药(02348.HK)宣布，公司将于2025年8月22日(星期五)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年6月30日止六个月之中期业绩及其刊发，以及考虑派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081117423797409294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081117423797409294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2555912886","title":"东瑞制药(02348)：胡硕获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2555912886","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555912886?lang=zh_cn&edition=full","pubTime":"2025-07-31 18:15","pubTimestamp":1753956957,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，胡硕先生已获委任为公司非执行董事，自2025年8月1日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2492512419","title":"主席李其玲增持东瑞制药(02348)18.4万股 每股作价1.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492512419","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492512419?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:05","pubTimestamp":1734437100,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，12月13日，主席李其玲增持东瑞制药(02348)18.4万股，每股作价1.2港元，总金额为22.08万港元。增持后最新持股数目为7.08亿股，最新持股比例为47.14%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-17/doc-inczurfi4699083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2488988539","title":"主席李其玲增持东瑞制药(02348)8.8万股 每股作价约1.21港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488988539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488988539?lang=zh_cn&edition=full","pubTime":"2024-12-03 16:26","pubTimestamp":1733214376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月29日，主席李其玲增持东瑞制药(02348)8.8万股，每股作价1.2132港元，总金额为10.68万港元。增持后最新持股数目为7.07亿股，持股比例为47.08%。本交易涉及其他关联方：熊融礼。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2480327046","title":"东瑞制药盘中异动 快速上涨7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480327046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480327046?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:42","pubTimestamp":1730706161,"startTime":"0","endTime":"0","summary":"2024年11月04日临近收盘15时42分，东瑞制药股票出现波动，股价急速上涨7.26%。截至发稿，该股报1.330港元/股，成交量7.6万股，换手率0.01%，振幅8.06%。资金方面，该股资金流入5320港元，流出7.932万港元。东瑞制药股票所在的药品行业中，整体涨幅为0.46%。其相关个股中，信达生物、中国医疗集团、海王英特龙涨幅较大，振幅较大的相关个股有顺腾国际控股、兴科蓉医药、三爱健康集团，振幅分别为22.22%、18.75%、10.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2479247918","title":"东瑞制药股价上涨11.20% 市值涨2.34亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479247918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479247918?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:58","pubTimestamp":1730271483,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘14时58分，东瑞制药股票出现异动，股价大幅上涨11.20%。截至发稿，该股报1.390港元/股，成交量3.6万股，换手率0.00%，振幅12.00%。资金方面，该股资金流入5560港元，流出3.972万港元。东瑞制药股票所在的药品行业中，整体跌幅为0.56%。其相关个股中，开拓药业-B、艾美疫苗、白花油涨幅较大，振幅较大的相关个股有翰森制药、泰凌医药、德琪医药-B，振幅分别为12.52%、12.12%、11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2474315255","title":"东瑞制药盘中异动 大幅跳水6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474315255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474315255?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:02","pubTimestamp":1728439365,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘10时02分，东瑞制药股票出现波动，股价大幅下跌6.92%。截至发稿，该股报1.210港元/股，成交量57.2万股，换手率0.04%，振幅2.31%。东瑞制药股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，三爱健康集团、培力农本方、康臣药业涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、华控康泰，振幅分别为32.98%、17.08%、12.50%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2473461132","title":"东瑞制药盘中异动 早盘急速跳水6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473461132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473461132?lang=zh_cn&edition=full","pubTime":"2024-10-08 10:36","pubTimestamp":1728355013,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘10时36分，东瑞制药股票出现异动，股价急速下跌6.47%。截至发稿，该股报1.300港元/股，成交量3.6万股，换手率0.00%，振幅2.16%。东瑞制药股票所在的药品行业中，整体跌幅为1.45%。其相关个股中，华控康泰、顺腾国际控股、长江生命科技涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、康龙化成，振幅分别为92.86%、45.18%、32.64%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2473143227","title":"东瑞制药盘中异动 临近午盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473143227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473143227?lang=zh_cn&edition=full","pubTime":"2024-10-07 11:40","pubTimestamp":1728272456,"startTime":"0","endTime":"0","summary":"2024年10月07日临近午盘11时40分，东瑞制药股票出现波动，股价急速上涨5.65%。截至发稿，该股报1.310港元/股，成交量254万股，换手率0.17%，振幅7.26%。东瑞制药股票所在的药品行业中，整体涨幅为0.22%。其相关个股中，三爱健康集团、德琪医药-B、四环医药涨幅较大，振幅较大的相关个股有三爱健康集团、德琪医药-B、艾美疫苗，振幅分别为152.70%、35.05%、28.89%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007114056a1de9aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007114056a1de9aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2472813996","title":"东瑞制药(02348)根据2023购股权计划授出合共1600万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2472813996","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472813996?lang=zh_cn&edition=full","pubTime":"2024-10-03 07:37","pubTimestamp":1727912244,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布公告，于2024年10月2日，公司根据2023购股权计划...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_21.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_21.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2471815452","title":"东瑞制药盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471815452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471815452?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:37","pubTimestamp":1727660221,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时37分，东瑞制药股票出现波动，股价快速拉升5.26%。截至发稿，该股报1.200港元/股，成交量86.8万股，换手率0.06%，振幅5.26%。东瑞制药股票所在的药品行业中，整体涨幅为0.35%。其相关个股中，艾美疫苗、康龙化成、德琪医药-B涨幅较大，振幅较大的相关个股有艾美疫苗、德琪医药-B、凯莱英，振幅分别为17.13%、16.18%、6.22%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300937019f1ffcd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300937019f1ffcd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0331},{"period":"3month","weight":-0.0331},{"period":"6month","weight":-0.1288},{"period":"1year","weight":0.0579},{"period":"ytd","weight":-0.041}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.036},{"period":"3month","weight":0.0225},{"period":"6month","weight":0.0536},{"period":"1year","weight":0.3578},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药（控股）有限公司是一家主要从事非专利药物的开发、制造及销售业务的投资控股公司。该公司通过两个部门运营业务。成药分部从事制造及销售成药。中间体及原料药分部从事制造及销售中间体及原料药。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":0.000907},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.005291},{"month":3,"riseRate":0.5,"avgChangeRate":0.02181},{"month":4,"riseRate":0.681818,"avgChangeRate":0.038102},{"month":5,"riseRate":0.5,"avgChangeRate":0.019208},{"month":6,"riseRate":0.590909,"avgChangeRate":0.008872},{"month":7,"riseRate":0.545455,"avgChangeRate":0.019288},{"month":8,"riseRate":0.347826,"avgChangeRate":-0.019446},{"month":9,"riseRate":0.478261,"avgChangeRate":0.022631},{"month":10,"riseRate":0.434783,"avgChangeRate":-0.001992},{"month":11,"riseRate":0.565217,"avgChangeRate":0.036336},{"month":12,"riseRate":0.565217,"avgChangeRate":0.012708}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}